Arena Pharmaceuticals

Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
TheStreet.com
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Flag link:
Arena takes a big step down the comeback trail with PhII success, shares rocket up
Arena takes a big step down the comeback trail with PhII success, shares rocket up
Endpoints
Arena Pharmaceuticals
PAH
clinical trials
pulmonary arterial hypertension
ralinepag
Flag link:
Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Friday
Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Friday
Motley Fool
Arena Pharmaceuticals
ralinepag
Belviq
Flag link:
Arena Pharmaceuticals beats 4Q profit forecasts
Arena Pharmaceuticals beats 4Q profit forecasts
Yahoo/AP
Arena Pharmaceuticals
earnings
Flag link:
Arena Turns Page On Belviq - Restructures Deal With Eisai
Arena Turns Page On Belviq - Restructures Deal With Eisai
Seeking Alpha
Arena Pharmaceuticals
Belviq
Eisai
Flag link:
Arena Pharmaceuticals reports 3Q loss
Arena Pharmaceuticals reports 3Q loss
Yahoo/AP
earnings
Arena Pharmaceuticals
Flag link:
Drug maker faces a shareholder suit for failing to tell the whole truth
Drug maker faces a shareholder suit for failing to tell the whole truth
Stat/Pharmalot
shareholders
Arena Pharmaceuticals
Belviq
Flag link:
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
Yahoo
Eisai
Arena Pharmaceuticals
Belviq XR
Flag link:
Arena Launches Drug Discovery Incubator (ARNA)
Arena Launches Drug Discovery Incubator (ARNA)
Investopedia
Arena Pharmaceuticals
R&D
drug discovery
Beacon Discovery
Flag link:
Arena to focus on R&D with new spinout and old candidates
Arena to focus on R&D with new spinout and old candidates
Fierce Biotech
Arena Pharmaceuticals
R&D
Beacon Discovery
Flag link:
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Marketwatch
Arena Pharmaceuticals
FDA
obesity
Eisai
Belviq XR
Flag link:
Arena - Anti-Obesity Drug Lorcaserin Approved In Mexico
Arena - Anti-Obesity Drug Lorcaserin Approved In Mexico
Seeking Alpha
Arena Pharmaceuticals
lorcaserin
obesity
Mexico
Flag link:
Arena's Q2 Will Demonstrate The Company's Need For Cash
Arena's Q2 Will Demonstrate The Company's Need For Cash
Seeking Alpha
Arena Pharmaceuticals
Flag link:
The Little-Known Reason Arena Pharmaceuticals Could Be a Winner
The Little-Known Reason Arena Pharmaceuticals Could Be a Winner
Motley Fool
Arena Pharmaceuticals
Belviq
CNS
Boehringer Ingelheim
Flag link:
Arena Investors: What To Consider As Anti-Obesity Drugs Fizzle
Arena Investors: What To Consider As Anti-Obesity Drugs Fizzle
Seeking Alpha
Arena Pharmaceuticals
obesity
Orexigen
Belviq
Eisai
Vivus
Novo Nordisk
Qsymia
Victoza
Flag link:
Arena Announces Clinical Trial Results For Pain Drug
Arena Announces Clinical Trial Results For Pain Drug
Seeking Alpha
APD371
Arena Pharmaceuticals
clinical trials
painkillers
Flag link:
Orexigen: Contrave Sales Flatten Out At End Of Q1
Orexigen: Contrave Sales Flatten Out At End Of Q1
Seeking Alpha
Orexigen
Contrave
obesity
Novo Nordisk
Vivus
Arena Pharmaceuticals
Flag link:
Eisai slashes Belviq sales force as Arena marketing deal goes sour
Eisai slashes Belviq sales force as Arena marketing deal goes sour
Fierce Pharma Marketing
Eisai
layoffs
drug reps
Belviq
Arena Pharmaceuticals
Flag link:
Arena: Belviq Sales Still Slow - Will Eisai Stick Around?
Arena: Belviq Sales Still Slow - Will Eisai Stick Around?
Seeking Alpha
Arena Pharmaceuticals
Belviq
Eisai
obesity
Flag link:
Arena Investors Hope Celgene Trial A Harbinger For Future Returns
Arena Investors Hope Celgene Trial A Harbinger For Future Returns
Seeking Alpha
Arena Pharmaceuticals
Celgene
ozanimod
APD334
ulcerative colitis
Flag link: